Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by kuatolives

ARLZQ

RE:RE:RE:RE:Zack's article and initiation report

Well, the market is huge, but now that lipitor (the biggest selling drug of...

February 28, 2016

ARLZQ

RE:RE:Zack's article and initiation report

Bezalip approval hasn't been filed in the US as far as anyone can tell...

February 28, 2016

ARLZQ

RE:RE:Zack's article and initiation report

Bass runs a hedge fund that files drug patent attacks while shorting the...

February 28, 2016

ARLZQ

Zack's article and initiation report

Yahoo article: https://finance.yahoo.com/news/arlz-strong-management-team...

February 26, 2016

ARLZQ

RE:RE:RE:Allow me to stir it up

These guys aren't bozos; they're not down at the pub every day...

February 26, 2016

ARLZQ

RE:Allow me to stir it up

Liquidity sucks, but I anticipate it will get better after the first couple...

February 25, 2016

ARLZQ

RE:Financials

Not sure. TMX and Nasdaq are typically 45 days after the close of the last...

February 24, 2016

ARLZQ

Starting to see some volume on the TMX

If only 20k shares ..... beats 4k.

February 23, 2016

ARLZQ

RE:RE:RE:RE:ARLZ stock action

I'm wondering who actually knew about TRX in Canada? It traded on the CVE...

February 19, 2016

ARLZQ

Lack of volume theories?

TRX got way more volume on the CVE. Curious as to why the TMX equivalent...

February 18, 2016

ARLZQ

RE:RE:ARLZ stock action

Couple of drugs in the near term pipeline, some earnings soon, cash in the...

February 18, 2016

ARLZQ

First!

First! 

February 17, 2016

V.TRX

RE:RE:Cdn Discount Closing

Next earnings and (hopefully) a Bilastine annoucement should be next in the...

February 17, 2016

V.TRX

RE:RE:RE:RE:Is this conversion from TRX to ARZ taxable?

Listening to a stock broker tell you to sell your stocks is like listening to...

February 16, 2016

V.TRX

RE:RE:RE:Is this conversion from TRX to ARZ taxable?

The last circular said TRX to ARZ was a taxable event. The last price TRX...

February 15, 2016

V.TRX

Shares converted

My shares finally converted, so I'm guessing it's the same story for...

February 12, 2016

V.TRX

RE:52 week Low!!...How low can we go?

Market wide firesale, not much you can do. I still think this isn't...

February 11, 2016

V.TRX

RE:RE:RE:RE:trx.v stocks

My bank shows no trading activity and I still don't see ARZ in any of my...

February 10, 2016

V.TRX

RE:trx.v stocks

The arbirtrage was in TRX's favor by a few percentage points and that...

February 10, 2016

V.TRX

Bilastine

Nichol Ochsner got back to me as to why Bilastine wasn't listed on the...

February 10, 2016

Prev ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... Next

Featured Company

Gemina Laboratories Ltd.

Gemina Laboratories Ltd. C.GLAB

Gemina Laboratories Ltd. is a Canada-based biosensor and diagnostic company with a transformative, patented, proprietary ... view more »